Company: NCEL
Filing Date: 2025-09-03
Form Type: F-4/A
Source: 0001213900-25-084157
Chunk: 269

Company: NewcelX Ltd.
Filing Date: 2025-09-03
Form: F-4/A
Chunk 269
---
 decision -makingprocess. However, Approval of the Merger and the Merger Agreement is a condition to the Closing under the Merger Agreement. Therefore, NLS may consummate the Merger only if it is approved by the affirmative vote of the holders of an absolute majority of all votes represented. To approve this Proposal1, a resolution passed by a Simple Majority Vote is required. You may vote “FOR,” “AGAINST” or “ABSTAIN” on Proposal 1. A failure to vote, an abstention or a broker non -vote, if any, will have the same effect as a vote “AGAINST” Proposal 1. THE NLS BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
“FOR” PROPOSAL 1. 108 Approval of PAR VALUE REDUCTION, REVERSE SPLIT AND ORDINARY SHARE CAPITAL INCREASE WITH CONTRIBUTION OF THE KADIMASTEM SHARES TO IMPLEMENT THE MERGER (PROPOSAL 2) Under Swiss law, share capital may be increased through a resolution of the shareholders’ meeting (ordinary capital increase), which must be implemented by the NLS Board within six months to become effective. The amount by which the capital can be increased in an ordinary capital increase is unlimited, provided that sufficient contributions are made to cover the capital increase. Further, Swiss law allows us to reduce the par value and to resolve on a reverse split. According to the Merger Agreement, each Kadimastem Ordinary Share will, by virtue of the Merger, be exchanged for and converted into the right to receive a newly issued, fully paid -inNLS Common Shares, based on an Exchange Ratio as set forth in the Merger Agreement. For the purpose of making available the required number of NLS Common Shares to serve as the Merger Consideration, or the Merger Consideration, for the Kadimastem shareholders, the Company has agreed to create the necessary Merger Consideration Shares by way of an ordinary capital increase, excluding the subscription rights of existing shareholders of the Company. Before that, the NLS Board proposes a par value reduction and a reverse split to optimize its capital structure. At the NLS Meeting, shareholders will be asked to approve a reverse split of the issued and outstanding NLS Common Shares within a range of two -for-one(2:1) to twenty -for-one(20:1), with the exact reverse split ratio to be decided no later than the morning of the NLS Meeting. If approved and implemented